Filip Pierlejewski
Overview
Explore the profile of Filip Pierlejewski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sekowska A, Czyzewski K, Jaremek K, Zalas-Wiecek P, Zajac-Spychala O, Wachowiak J, et al.
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064118
is a nosocomial pathogen that causes severe infections in immunocompromised patients. The aim of the study was to conduct a microbiological and clinical analysis of infections in children with malignancies...
2.
Zawitkowska J, Drabko K, Lejman M, Kowalczyk A, Czyzewski K, Dziedzic M, et al.
Sci Rep
. 2023 Dec;
13(1):22619.
PMID: 38114744
The most common complications related to the treatment of childhood acute lymphoblastic leukemia (ALL) are infections. The aim of the study was to analyze the incidence and mortality rates among...
3.
Zawitkowska J, Drabko K, Czyzewski K, Dziedzic M, Jaremek K, Zalas-Wiecek P, et al.
Pathogens
. 2022 Oct;
11(10).
PMID: 36297147
Viral infections can be a serious complication of therapy in children with acute lymphoblastic leukemia (ALL). In this study, we focused on the incidence and the profile of viral infection...
4.
Richert-Przygonska M, Czyzewski K, Dziedzic M, Zalas-Wiecek P, Gryniewicz-Kwiatkowska O, Gietka A, et al.
Pediatr Infect Dis J
. 2022 Jul;
41(10):846-850.
PMID: 35797710
Background: Infections caused by Stenotrophomonas maltophilia (SM) have documented high mortality rate in immunocompromised patients. Aim: This nationwide multicenter study was performed to analyze the epidemiology of SM infections in...
5.
Weclawek-Tompol J, Zakrzewska Z, Gryniewicz-Kwiatkowska O, Pierlejewski F, Bien E, Zaucha-Prazmo A, et al.
J Hematol Oncol
. 2022 May;
15(1):71.
PMID: 35637467
No abstract available.
6.
Weclawek-Tompol J, Zakrzewska Z, Gryniewicz-Kwiatkowska O, Pierlejewski F, Bien E, Zaucha-Prazmo A, et al.
J Hematol Oncol
. 2021 Oct;
14(1):163.
PMID: 34635137
Background: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) currently constitutes the leading and overwhelming health issue worldwide. In comparison with adults, children present milder...
7.
Zajac-Spychala O, Wachowiak J, Gryniewicz-Kwiatkowska O, Gietka A, Dembowska-Baginska B, Semczuk K, et al.
Microb Drug Resist
. 2020 May;
27(1):53-63.
PMID: 32434455
Infectious complications (IC) caused by bacterial strains often impede anticancer therapy. The study aimed to retrospectively analyze bacterial IC that could help predict the risk and optimize the empirical treatment...
8.
Zawitkowska J, Lejman M, Szmydki-Baran A, Zaucha-Prazmo A, Czyzewski K, Dziedzic M, et al.
J Med Virol
. 2020 May;
92(12):3645-3649.
PMID: 32406935
Varicella-zoster virus (VZV) infection in pediatric hemato-oncology patients can be a therapeutic problem when children are exposed to immunosuppression. The aim of this study is to evaluate the incidence of...
9.
Czyzewski K, Galazka P, Fraczkiewicz J, Salamonowicz M, Szmydki-Baran A, Zajac-Spychala O, et al.
Mycoses
. 2019 Aug;
62(11):990-998.
PMID: 31429997
The objective of the study was the analysis of incidence and outcome of invasive fungal disease (IFD) in children treated for malignancy (PHO, paediatric hematology-oncology) or undergoing hematopoietic cell transplantation...
10.
Czyzewski K, Galazka P, Zalas-Wiecek P, Gryniewicz-Kwiatkowska O, Gietka A, Semczuk K, et al.
Infect Drug Resist
. 2019 Jun;
12:1471-1480.
PMID: 31213862
The analysis of epidemiology, risk factors and outcome of infections in children with malignant bone tumors (MBT) undergoing chemotherapy. In this retrospective nationwide multicenter cross-sectional study, a total number of...